50742-193 : Tolcapone 100 mg Oral Tablet
| NDC: | 50742-193 |
| Labeler: | Ingenus Pharmaceuticals, LLC |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Tolcapone |
| Dosage Form: | Oral Tablet |
| Application #: | ANDA208937 |
| Rev. Date: |
Appearance:
| Markings: | RA;10 |
| Shapes: |
Oval |
| Colors: |
 Yellow |
| Size (mm): | 9 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 50742-193-90: 90 TABLET IN 1 BOTTLE (50742‑193‑90)
Active Ingredients:
- Tolcapone
Dosage Strength:
- 100 mg
Inactive Ingredients:
- Lactose Monohydrate
- Cellulose, Microcrystalline
- Anhydrous Dibasic Calcium Phosphate
- Sodium Starch Glycolate Type a Potato
- Povidone K30
- Talc
- Magnesium Stearate
- Hypromellose, Unspecified
- Titanium Dioxide
- Ethylcellulose, Unspecified
- Triacetin
- Sodium Lauryl Sulfate
- Ferric Oxide Yellow /
Pharmaceutical Classes:
- Catechol O-Methyltransferase Inhibitors [MoA]
- Catechol-O-Methyltransferase Inhibitor [EPC]
Related Products:
Based on records with the same trade name.- 49884-254 Tolcapone 100 1/1 Oral Tablet, Coated by Par Pharmaceutical Companies, Inc.
- 68682-938 Tolcapone 100 mg Oral Tablet, Film Coated by Oceanside Pharmaceuticals
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 50742-191Next: 50742-201 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.